2 DISTINCT SIGNALS REGULATE INDUCTION OF IL-2 RESPONSIVENESS IN CD8+ MURINE T-CELLS

被引:0
作者
WAGNER, H [1 ]
HEEG, K [1 ]
机构
[1] UNIV ULM, DEPT MED MICROBIOL & IMMUNOL, OBERER ESELSBERG, D-7900 ULM, FED REP GER
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In the model system used here, cross-linking of T-cell receptor structures (TCR) by antigen-presenting cells (APCs) is substituted by the use of anti-F23.1 anti-T-cell receptor monoclonal antibody immobilized on Sepharose beads. We show that Cr cross-linking of resting murine CD8+ T cells seeded at low cell densities is insufficient to induce responsiveness to the growth-promoting effect of interleukin-2 (IL-2), i.e. fails to induce expression of functional IL-2 receptors. The macrophage cell-line product, IL-2 receptor-inducing factor (RIF), but not IL-1, IL-3, IL-4 and interferon-gamma (IFN-.gamma.), functions efficiently as a co-stimulator. Once activated, growth of CD8+ T cells is driven entirely by IL-2. We conclude that two restriction points control the activation of resting CD8+ T cells. While cross-linking of TCR is essential as the first step, RIF is required as the competence factor to induce IL-2 responsiveness. We consider the possibility that the ability of APCs to produce RIF determines the immunogenicity of APCs towards antigen-reactive resting CD8+ T cells.
引用
收藏
页码:433 / 438
页数:6
相关论文
共 50 条
  • [31] DISTINCTION BETWEEN MURINE CD8+ CTL AND SUPPRESSOR T-CELLS
    KAPP, J
    DEVENS, B
    PIERCE, C
    WEBB, D
    FASEB JOURNAL, 1992, 6 (04) : A1415 - A1415
  • [32] IL-2 relieves G(1) cell cycle arrest in CD8+ T-cells from HIV+ individuals.
    Lempicki, RA
    Pavlick, MV
    Donoghue, ET
    Kovacs, J
    Adelesberger, J
    Baseler, M
    Lane, HC
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 432 - 432
  • [33] Tumor-targeted IL-2 by engineered mesenchymal stem cells reinvigorates CD8+ T cells
    Bae, Joonbeom
    Liu, Longchao
    Timmerman, Casey
    Hsu, Eric
    Zhang, Anli
    Zhu, Jiankun
    Fu, Yang-Xin
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
  • [34] CD8+ T-CELLS IN ALLERGY
    KEMENY, DM
    DIAZSANCHEZ, D
    HOLMES, BJ
    ALLERGY, 1992, 47 (01) : 12 - 21
  • [35] ROLE OF CD8+ T-CELLS IN MURINE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
    JIANG, H
    ZHANG, SL
    PERNIS, B
    SCIENCE, 1992, 256 (5060) : 1213 - 1215
  • [36] Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy
    Furusawa, Aki
    Reiser, John
    Sadashivaiah, Kavitha
    Simpson, Haley
    Banerjee, Arnob
    JOURNAL OF IMMUNOTHERAPY, 2018, 41 (02) : 53 - 63
  • [37] IL-2 and IL-15 regulate CD8+ memory T-cell differentiation but are dispensable for protective recall responses
    Mathieu, Cedric
    Beltra, Jean-Christophe
    Charpentier, Tania
    Bourbonnais, Sara
    Di Santo, James P.
    Lamarre, Alain
    Decaluwe, Helene
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2015, 45 (12) : 3324 - 3338
  • [39] IL-2-induced growth of CD8+ T cell prolymphocytic leukemia cells mediated by NF-κB induction and IL-2 receptor α expression
    Arima, N
    Matsushita, K
    Suruga, Y
    Ohtsubo, H
    Fujiwara, H
    Hidaka, S
    Arimura, K
    Kukita, T
    Yamaguchi, K
    Fukumori, J
    Tanaka, H
    LEUKEMIA RESEARCH, 1998, 22 (03) : 265 - 273
  • [40] INDUCTION OF NEONATAL TOLERANCE TO MLSA ANTIGENS BY CD8+ T-CELLS
    WEBB, SR
    SPRENT, J
    SCIENCE, 1990, 248 (4963) : 1643 - 1646